CYFRA21-1(Cytokeratin 19 fragments)
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnostic reagent, cancer diagnosis, tumor marker
- Category
- Medical Devices
Tellgen corporation
China
- Verified Certificate
-
9
| Product name | CYFRA21-1(Cytokeratin 19 fragments) | Certification | - |
|---|---|---|---|
| Category | Medical Devices | Ingredients | - |
| Keyword | diagnostic reagent , cancer diagnosis , tumor marker | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | China | Stock | - |
| Supply type | - | HS code | - |
Product Information
CYFRA 21-1 (Cytokeratin 19 Fragment)
Compitable instrument: Luminex 200,TESMI F4000 .
Reference Value:5ng/ml
Tellgen also provide following Tumor markers and Tumor Marker control :
CA125
CA153
CA24-2
CYFRA21-1
AFP
CEA
CEA
total PSA
free PSA
free-beta-hCG
CA19-9
NSE
SCCA
CA72-4
CA50
HE4
ProGRP
PGI/PGII
Control 1
Control 2
Control 3
The CYFRA 21-1 kit is intended for the quantitative determination of soluble
cytokeratin 19 fragments in human serum. The assay is to be used as an aid in
monitoring disease progression during the course of disease and treatment in lung
cancer patients. Serial testing for patient CYFRA 21-1 assay values should be
used in conjunction with other clinical methods used for monitoring lung cancer.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Yao Jiaoer
- Address
- Building 1, No.115, Lane 572, Bibo road, Free trade area
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2003
- No. of Total Employees
- 101-500
- Company introduction
-
Shanghai Tellgen Corporation. was founded in 2003 and dedicated exclusively to the development, production and distribution of high-quality automated workflow solutions for research and clinical diagnostics laboratories in the life sciences sector. With the tremendous development, Tellgen became the the market leader in moleucular diagnosis area, and had consistently delivered series diagnostic products for healthcare
- Main Product
